Vera Therapeutics Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, specializing in the development of innovative therapies for serious immune-mediated diseases. With a robust pipeline of drug candidates targeting significant unmet medical needs, Vera is dedicated to improving patient outcomes through advanced immunological research. The company's strategic focus on redefining treatment paradigms positions it for potential transformative impacts within the healthcare landscape, thereby presenting an intriguing opportunity for institutional investors interested in pioneering biopharmaceutical advancements. Show more

Location: 2000 SIERRA POINT PARKWAY, BRISBANE, CA, UNITED STATES, 94005, Brisbane, CA, 94005, USA | Website: https://veratx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

3.071B

52 Wk Range

$18.53 - $56.05

Previous Close

$43.26

Open

$42.96

Volume

1,106,366

Day Range

$42.93 - $45.38

Enterprise Value

2.345B

Cash

57.77M

Avg Qtr Burn

-61.91M

Insider Ownership

0.88%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Atacicept Details IgA nephropathy	BLA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Atacicept Details Lupus nephritis	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MAU868 Details Kidney transplantation, BK virus	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.